- Home
- FNKO vs ALEC Comparison
FNKO vs ALEC Comparison
Compare FNKO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FNKO | ALEC |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.8M | 194.3M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FNKO | ALEC |
|---|---|---|
| Price | $5.75 | $1.88 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $6.00 | $4.83 |
| AVG Volume (30 Days) | 579.2K | ★ 875.1K |
| Earning Date | 05-07-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $908,209,000.00 | $21,045,000.00 |
| Revenue This Year | $4.42 | $2.03 |
| Revenue Next Year | $6.50 | $29.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.22 | $1.09 |
| 52 Week High | $6.09 | $3.40 |
Technical Indicators
Market Signals| Indicator | FNKO | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 63.84 | 52.52 |
| Support Level | $5.06 | $1.14 |
| Resistance Level | $6.09 | $2.64 |
| Average True Range (ATR) | 0.31 | 0.15 |
| MACD | 0.02 | 0.05 |
| Stochastic Oscillator | 97.09 | 78.69 |
Price Performance
Historical ComparisonAbout FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.